SPOTLIGHT -
One particular disease state, multiple sclerosis (MS), deserves specific attention at this time because there are several therapeutic treatment options available today.
FDA Updates for the Week of Nov. 20, 2023
FDA has approved a new therapy for HR positive breast cancer and announces plan to hold advisory meeting for Abecma in earlier treatment of multiple myeloma. In addition, Janssen has submitted a supplemental application for Rybrevant in NSCLC.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
COVID-19 Vaccination Reduces Symptoms and Improves Work Productivity, Pfizer Study Shows
AI Improving Healthcare Efficiency, the Evolution of VBC, Reducing Healthcare Waste and More With William Shrank of Andreessen Horowitz
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Understanding the Average Sales Price Landscape
The potential promise of prescription digital therapeutics in mental health disorders